Matthew Feshbach, co-founder of Okyanos Cell Therapy, will tell the story of founding, developing and launching the company’s purpose-built center at the upcoming Regenera Global Conference to be held in Freeport, Grand Bahama on June 23-25.
FREEPORT, Grand Bahama (PRWEB) JUNE 06, 2016 – Matthew Feshbach, CEO and co-founder of Okyanos Cell Therapy, will share his vision for establishing cell therapy as a worldwide standard of care for chronic, degenerative diseases at the upcoming Regenera Global Conference, “Regenerative Medicine 2.0: Redefining the Practice,” to be held in Freeport, Grand Bahama on June 23-25, 2016. Feshbach will also address some of the challenges experienced in the development and launch of Okyanos with the hope that peers may use these insights to achieve success in bringing safe, beneficial adult stem cell therapies to chronically ill patients.
…continue >